In the present study, we found that the level of Cav-1 in the hippocampus of AD mice was upregulated after Ca treatment, whereas significantly downregulated upon miR-138-5p knockdown, suggesting Ca may also mediate AD progression though miR-138-5p/Cav-1 axis. The gene discussed is CAV1; the disease is Alzheimer disease.